Struggling with bispecific antibody development?

Not sure which format to choose?
Need an IP-free solution?
Looking for the right balance between efficacy, yield, and stability?

Derisk your bispecific antibody development with a go/no go approach

Our platform is built to solve complex development challenges thanks to a unique combination of scientific expertise and a pragmatic, results-driven approach including several go/no-go checkpoints.

Our approach
8 weeks from design to validation

Strategic scientific consulting

Define the optimal format to test, from IgG-like architectures to more complex or compact designs, based on your goals.
High-throughput screening

Rapidly produce and evaluate multiple bispecific formats in parallel to identify the most promising candidates early.
Comprehensive validation

Go beyond basic characterization with in-depth evaluation of: functional activity, expression yield and molecular stability.